BSXNYSEHealthcare
Boston Scientific (BSX) seasonality
Boston Scientific Corporation (BSX) seasonality: across 33 complete years (1993–2025), BSX's strongest month has been January (average +5.4%, higher in 21 of 33 years) and its weakest September (average −2.4%, higher in 13 of 33 years). Over the 20 trading sessions after , it rose in 17 of 33 past years, with an average move of −0.9%. Data through . Historical averages, not a forecast.
Historical averages from daily closing prices, not a forecast and not investment advice. Disclaimer · Methodology
BSX seasonality at a glance
| Month | Average | Median | Years higher | Best year | Worst year |
|---|---|---|---|---|---|
| January Best | +5.4% | +7.4% | 21 of 33 (64%) | +30.4% (2013) | −10.7% (2006) |
| February | +0.4% | +1.0% | 18 of 33 (55%) | +17.7% (1998) | −20.9% (2009) |
| March | +2.5% | +0.4% | 19 of 33 (58%) | +53.1% (1999) | −14.2% (1993) |
| April | +1.9% | +3.6% | 22 of 33 (67%) | +24.3% (2000) | −21.9% (1997) |
| May | +2.0% | +2.3% | 20 of 33 (61%) | +23.4% (2013) | −12.1% (2010) |
| June | +0.7% | +0.3% | 17 of 33 (52%) | +17.3% (2003) | −18.6% (2006) |
| July | +1.3% | +2.3% | 20 of 33 (61%) | +17.8% (2013) | −24.5% (2000) |
| August | +0.6% | −0.8% | 16 of 33 (48%) | +22.0% (1994) | −16.3% (1999) |
| September Worst | −2.4% | −2.3% | 13 of 33 (39%) | +24.7% (1996) | −27.3% (1999) |
| October | −0.4% | −0.4% | 15 of 33 (45%) | +24.6% (1993) | −26.4% (2008) |
| November Now | −0.8% | 0.0% | 16 of 33 (48%) | +17.0% (2001) | −31.7% (2008) |
| December | +3.4% | +3.0% | 25 of 33 (76%) | +25.4% (2008) | −9.5% (2011) |
Current seasonal picture · November 13, 2026
As of November 13, 2026, Boston Scientific Corporation is −53.5% year to date. Across 33 complete years (1993–2025), the average at this point of the year was +14.3%, so BSX is running behind its seasonal average by 67.8 percentage points. A year ago on the same date it was +17.5% year to date.
Over the next 20 trading days (about four weeks) from this date, BSX historically averaged −0.9% (median +0.9%) and rose in 17 of 33 years (52%). Best: +10.8% in 2022; worst: −20.9% in 1997. For comparison, SPY (the S&P 500) averaged +1.3% over the same window, up in 23 of 32 years, so BSX's seasonal edge over the market for this window is −2.2%.
In the last 20 sessions, BSX moved in the same direction as its seasonal average on 9 of 20 days (45%), close to the 50% you would expect by chance.
Within the next 60 days, the historically strongest 10-session window began around January 3 (average +5.4%, up in 20 of 28 years) and the weakest around November 13 (average −1.3%, up in 15 of 33 years).
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Next trading week (Monday to Friday): will BSX close up, flat or down?
A free poll for fun and research: no stakes, no prizes, not advice. One vote per person per week; you can change it until the week starts. Results are scored from closing prices after the week ends. All results · My calls
BSX seasonal charts
Seasonality by calendar date
Each line is one calendar year of Boston Scientific Corporation, measured as its return since the previous year's final close (year to date) and drawn on a common January-to-December axis. The bold average line shows where BSX has typically stood on each date across every complete year on file.
How the average is built. Returns are compounded from daily closing prices. Every year counts on every date: on weekends and market holidays a year keeps its last close, so the average is never built from a different mix of years on different days. Only complete calendar years enter the average, so a partial current year or a mid-year listing cannot distort it. This view surfaces date-anchored effects such as tax-loss selling into December, the January effect, quarter-end rebalancing and recurring earnings seasons.
Day-of-year seasonality for BSX
The bold blue line is the multi-year average and orange is the current year; thinner coloured lines are the most recent years, and older years appear in grey when you choose All years. When the current-year line sits above the average, BSX is ahead of its usual pace for the date. Hover any point to compare each year with the average on that day.
What the data says now · November 13, 2026
As of November 13, 2026, Boston Scientific Corporation is −53.5% year to date. Across 33 complete years (1993–2025), the average at this point of the year was +14.3%, so BSX is running behind its seasonal average by 67.8 percentage points. A year ago on the same date it was +17.5% year to date.
This year's path so far has a correlation of -0.93 with the seasonal average (1 would be a perfect match, 0 no relationship), so this year has not followed the typical seasonal shape.
The past years whose path most resembled 2026 up to this date: 2010 (next 20 sessions: +5.2%), 2005 (next 20 sessions: +1.7%), 1993 (next 20 sessions: −12.9%).
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Seasonality by week and weekday
Here each session is placed by its week number and weekday instead of its date. Weeks run Sunday to Saturday and week 1 is the week that contains January 1. Because calendar dates shift by a day or two each year, week numbers line up comparable sessions: week 14 ran from Monday, April 1 to Friday, April 5 in 2024, from March 31 to April 4 in 2025 and from March 30 to April 3 in 2026. Comparing "week 14, Monday" across years therefore compares the first Monday of the second quarter each time, which a fixed date such as April 1 cannot do.
Use this view for weekday tendencies (soft Mondays, strong Fridays) and to see how a pattern drifts week by week through the year. Each point is the year-to-date return at that week and weekday, averaged across complete years.
Year-to-date path by week number and weekday
Each line is one year building through the weeks; the bold line is the average. Where the yearly lines bunch together, the pattern repeated year after year; where they fan out, that stretch of the calendar was driven by events rather than the season. Labels read "week - weekday", for example "14 - Mon".
What the data says now · November 13, 2026
Over the last ten years, BSX's strongest weekday was Wednesday (average +0.21%, up on 55% of Wednesdays) and its weakest was Monday (−0.12%, up on 49%). Differences this small are easily swamped by news, so read them as tendencies, not rules.
For the coming week (the next 5 sessions from November 13, 2026), BSX historically averaged −1.2% and rose in 18 of 33 years.
In the last 8 completed weeks, the weekly move matched the direction of the seasonal average in 3 of 8.
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
Seasonality by trading day of the month
Sessions are numbered by their position inside each month: trading day 1 is the first session of the month, day 2 the second, whatever the calendar date. Most months have 19 to 23 sessions. Lining months up this way exposes flow-driven effects that calendar dates blur, such as pension and payroll inflows around the turn of the month, mid-month options expiry and fund rebalancing in the final sessions.
The chart runs from the first trading day of January to the last trading day of December, so each point is the year-to-date return after that session. On the axis, trading day N of a month is drawn at day N of that month.
Year-to-date path by trading day of the month for BSX
Steps that recur at the same point of every month, a rise over the first few sessions or a dip before month-end, are the signature of flows rather than news. Compare the slope of the average around the start and end of each month with the middle weeks.
What the data says now · November 13, 2026
After 10 trading days of November, BSX is +5.6% month to date. At the same point of November in past years it averaged +0.2% (median +0.2%, up in 18 of 33 years).
Turn of the month: over the last ten years, the last two and first three trading days of each month averaged +0.10% per day, versus +0.07% on the other days.
Calculated from daily closing prices (compounded, excluding dividends) for complete calendar years. Past patterns do not predict future results; this is not investment advice.
BSX seasonality vs the S&P 500
BSX seasonality compared with the S&P 500 (SPY)
Both lines are average year-to-date returns over the same complete years, so the comparison is like for like. The dashed line is the gap: when it rises, BSX has typically outperformed the market over that stretch of the calendar; when it falls, it has typically lagged. A stock with a strong seasonal line can still trail the market if SPY rises even more in the same weeks.
Measured over the same 32 complete years (1994–2025), BSX's average calendar year ended +19.1% against +10.3% for SPY. The month in which BSX typically gained most on the market was Jan (+4.6% relative), and the month it typically lost most ground was Oct (−3.0%).
Show the numbers
| End of | BSX | SPY | Gap |
|---|---|---|---|
| Jan | +5.3% | +0.7% | +4.6% |
| Feb | +6.4% | +0.9% | +5.6% |
| Mar | +9.6% | +1.4% | +8.2% |
| Apr | +11.8% | +3.2% | +8.6% |
| May | +13.9% | +4.2% | +9.7% |
| Jun | +15.7% | +4.4% | +11.3% |
| Jul | +17.5% | +6.0% | +11.5% |
| Aug | +18.5% | +5.8% | +12.7% |
| Sep | +16.7% | +5.1% | +11.6% |
| Oct | +15.3% | +6.8% | +8.5% |
| Nov | +15.3% | +9.6% | +5.8% |
| Dec | +19.1% | +10.3% | +8.8% |
Calendar date vs week and weekday vs trading day of the month
The averages from methods 1, 2 and 3 above, placed on one calendar axis (week slots and trading days are drawn on the dates they fell on in 2021). Lines that overlap mean the seasonal pattern holds however you count the sessions; a gap shows where an effect depends on the counting, typically around month ends and holidays.
All three methods measure the same thing, the average year-to-date return across 33 complete years, but line the sessions up differently. For BSX they agree closely: the largest gap between them is 1.6 percentage points around April 5. Where the lines separate, the effect depends on how you count (by date, by weekday or by session of the month); where they overlap, the pattern is robust to the method.
Show the numbers
| End of | Calendar date | Week & weekday | Trading day |
|---|---|---|---|
| Jan | +5.4% | +5.4% | +5.3% |
| Feb | +5.9% | +6.2% | +5.8% |
| Mar | +8.6% | +9.0% | +8.6% |
| Apr | +10.5% | +10.9% | +10.5% |
| May | +12.7% | +12.3% | +12.4% |
| Jun | +14.2% | +14.1% | +14.2% |
| Jul | +16.1% | +16.4% | +16.1% |
| Aug | +16.8% | +16.8% | +16.6% |
| Sep | +14.6% | +14.5% | +14.6% |
| Oct | +13.7% | +13.8% | +13.4% |
| Nov | +13.6% | +13.8% | +13.6% |
| Dec | +17.3% | +17.3% | +17.3% |
BSX monthly returns heatmaps
Intraday momentum. Each cell sums the daily open-to-close percent changes inside that month, leaving out the overnight gaps between one close and the next open. Compare it with the next heatmap to see whether a month's gains came during trading hours or overnight. Very old years can show 0.00 where the data source recorded a single price per day.
Held through the month. Each cell is the change from the first session open to the last session close — the return of entering on day one and exiting on the final bar.
BSX earnings, revenue and company events
Earnings reaction history · 89 reports since Oct 2004
On the first trading session after its earnings releases, BSX closed higher 46 of 89 times (52%), with a typical move of ±3.9%. Average reaction by fiscal quarter: Q1 +1.7% (up 14 of 22) · Q2 +1.2% (up 13 of 22) · Q3 −1.1% (up 8 of 23) · Q4 −0.8% (up 11 of 22).
Across 88 reports with full windows, the stock moved +0.1% on average in the 15 sessions before the report and +0.5% in the 15 sessions after the reaction day.
The latest report was released on October 28, 2026 (before the open) for fiscal Q3 2026; the stock moved −5.84% on the reaction day.
Report dates and actual EPS come from the company's SEC filings; price moves from daily closes. Analyst estimates are not shown. Past reactions do not predict the next one. Reports before late 2004 are not included: companies have flagged earnings releases in SEC filings (Form 8-K, Item 2.02) only since August 2004, while BSX's price history goes back to 1992.
Post-earnings price move: the last 12 reports and the average
0 is the first session after the release; each line is the change from the close before it. Thin lines are single reports, coloured by fiscal quarter (solid = latest, dashed = a year earlier, dotted = two years earlier); the thick line is the average of all reports. Use the buttons to switch to averages by quarter, or click any legend item.
| Released | Timing | Fiscal quarter | EPS (diluted) | EPS vs year ago | Reaction day | 15 sessions before | 15 sessions after |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Before open | Q3 2026 | $0.40 | −22% | −5.84% | +6.8% | – |
| Jul 29, 2026 | Before open | Q2 2026 | $0.61 | +15% | −0.04% | +1.7% | +13.0% |
| Apr 22, 2026 | Before open | Q1 2026 | $0.90 | +100% | +8.99% | −5.4% | −18.2% |
| Feb 4, 2026 | Before open | Q4 2025 | $0.45* | – | −17.59% | −4.3% | +0.3% |
| Oct 22, 2025 | Before open | Q3 2025 | $0.51 | +59% | +3.95% | +2.3% | +0.3% |
| Jul 23, 2025 | Before open | Q2 2025 | $0.53 | +141% | +4.46% | −4.0% | −4.9% |
| Apr 23, 2025 | Before open | Q1 2025 | $0.45 | +36% | +4.07% | −5.8% | +4.1% |
| Feb 5, 2025 | Before open | Q4 2024 | $0.38* | – | +1.38% | +9.4% | −4.0% |
| Oct 23, 2024 | Before open | Q3 2024 | $0.32 | −6% | −0.64% | +4.6% | +1.5% |
| Jul 24, 2024 | Before open | Q2 2024 | $0.22 | +22% | −1.06% | +2.9% | −1.7% |
| Apr 24, 2024 | Before open | Q1 2024 | $0.33 | +57% | +5.68% | +2.3% | +2.1% |
| Jan 31, 2024 | Before open | Q4 2023 | $0.34* | – | +3.00% | +5.1% | +5.5% |
| Oct 26, 2023 | Before open | Q3 2023 | $0.34 | +183% | −0.42% | −3.0% | +9.8% |
| Jul 27, 2023 | Before open | Q2 2023 | $0.18 | +6% | +0.46% | −1.6% | −3.2% |
| Apr 26, 2023 | Before open | Q1 2023 | $0.21 | +200% | −0.02% | +2.8% | +4.5% |
| Feb 1, 2023 | Before open | Q4 2022 | $0.09* | – | +2.79% | +1.5% | −0.8% |
| Oct 26, 2022 | Before open | Q3 2022 | $0.12 | −57% | +1.19% | +0.7% | +2.9% |
| Jul 27, 2022 | Before open | Q2 2022 | $0.17 | +42% | +6.19% | +0.5% | +5.3% |
| Apr 27, 2022 | Before open | Q1 2022 | $0.07 | −70% | +1.08% | −3.5% | −6.6% |
| Feb 2, 2022 | Before open | Q4 2021 | $0.06* | – | −4.74% | +2.6% | +6.1% |
| Oct 27, 2021 | Before open | Q3 2021 | $0.28 | – | −1.33% | +4.4% | −4.9% |
| Jul 27, 2021 | Before open | Q2 2021 | $0.12 | – | +3.50% | +0.1% | −0.8% |
| Apr 28, 2021 | Before open | Q1 2021 | $0.23 | +2,200% | +4.32% | +8.9% | −6.4% |
| Feb 3, 2021 | Before open | Q4 2020 | $0.14* | – | +2.21% | +0.6% | +5.9% |
| Oct 28, 2020 | Before open | Q3 2020 | $-0.12 | −233% | −5.49% | −8.3% | +0.6% |
| Jul 29, 2020 | Before open | Q2 2020 | $-0.11 | −200% | +4.02% | +10.5% | −1.2% |
| Apr 29, 2020 | Before open | Q1 2020 | $0.01 | −97% | +4.17% | +9.3% | −0.7% |
| Jan 14, 2020 | Before open | Q4 2019 | $2.83* | – | −6.18% | +1.4% | −0.1% |
| Oct 23, 2019 | Before open | Q3 2019 | $0.09 | −71% | +5.00% | −5.1% | +3.3% |
| Jul 24, 2019 | Before open | Q2 2019 | $0.11 | −73% | −0.02% | −0.1% | −3.4% |
| Apr 24, 2019 | Before open | Q1 2019 | $0.30 | +43% | −1.25% | −7.2% | +4.6% |
| Feb 6, 2019 | Before open | Q4 2018 | $0.27* | – | +2.70% | +6.9% | +3.5% |
| Oct 24, 2018 | Before open | Q3 2018 | $0.31 | +55% | −0.97% | −7.7% | +1.5% |
| Jul 25, 2018 | Before open | Q2 2018 | $0.40 | +264% | +2.23% | +2.3% | +1.7% |
| Apr 25, 2018 | Before open | Q1 2018 | $0.21 | 0% | +3.23% | +3.8% | +1.9% |
| Feb 1, 2018 | Before open | Q4 2017 | $-0.44* | – | −1.18% | 0.0% | −1.6% |
| Oct 26, 2017 | Before open | Q3 2017 | $0.20 | +18% | −2.67% | +1.3% | −1.9% |
| Jul 27, 2017 | Before open | Q2 2017 | $0.11 | – | −1.35% | −0.8% | −1.5% |
| Apr 27, 2017 | Before open | Q1 2017 | $0.21 | +40% | +0.81% | +5.4% | −0.2% |
| Feb 2, 2017 | Before open | Q4 2016 | $0.08* | – | +4.76% | +1.5% | −1.3% |
| Oct 26, 2016 | Before open | Q3 2016 | $0.17 | – | −1.56% | −3.6% | −3.3% |
| Jul 28, 2016 | Before open | Q2 2016 | $-0.15 | −288% | +2.87% | −0.0% | −1.6% |
| Apr 27, 2016 | Before open | Q1 2016 | $0.15 | – | +11.17% | +2.7% | +1.8% |
| Feb 4, 2016 | Before open | Q4 2015 | $-0.11* | – | −2.20% | −0.3% | −0.8% |
| Oct 28, 2015 | Before open | Q3 2015 | $-0.15 | −600% | +9.39% | +1.5% | −3.4% |
| Jul 23, 2015 | Before open | Q2 2015 | $0.08 | – | −2.28% | +1.8% | −2.0% |
| Apr 28, 2015 | Before open | Q1 2015 | $0.00 | −100% | −1.28% | +1.7% | +2.1% |
| Feb 4, 2015 | Before open | Q4 2014 | $-0.22* | – | +2.12% | +0.5% | +12.4% |
| Oct 22, 2014 | Before open | Q3 2014 | $0.03 | – | +2.41% | +1.9% | +8.9% |
| Jul 24, 2014 | Before open | Q2 2014 | $0.00 | −100% | +1.84% | +0.2% | −5.1% |
| Apr 29, 2014 | Before open | Q1 2014 | $0.10 | – | −6.26% | +0.6% | −0.9% |
| Feb 4, 2014 | Before open | Q4 2013 | $0.07* | – | −1.23% | −0.8% | +3.8% |
| Oct 24, 2013 | Before open | Q3 2013 | $0.00 | – | −6.10% | +4.6% | +3.6% |
| Jul 25, 2013 | Before open | Q2 2013 | $0.10 | – | +12.70% | +4.8% | +1.6% |
| Apr 25, 2013 | Before open | Q1 2013 | $-0.26 | −425% | +2.45% | −5.0% | +19.9% |
| Jan 29, 2013 | Before open | Q4 2012 | $0.02* | – | +3.50% | +15.9% | +2.7% |
| Oct 18, 2012 | Before open | Q3 2012 | $-0.48 | −633% | −3.91% | +0.2% | −3.5% |
| Jul 26, 2012 | Before open | Q2 2012 | $-2.51 | −2,610% | −6.75% | −8.1% | +10.9% |
| Apr 19, 2012 | Before open | Q1 2012 | $0.08 | +167% | +5.60% | −10.4% | +7.4% |
| Feb 2, 2012 | Before open | Q4 2011 | $0.07* | – | −4.11% | +10.1% | +7.0% |
| Oct 20, 2011 | Before open | Q3 2011 | $0.09 | −25% | −4.43% | −7.4% | +8.7% |
| Jul 28, 2011 | Before open | Q2 2011 | $0.10 | +67% | +8.49% | −6.3% | −16.8% |
| Apr 20, 2011 | After close | Q1 2011 | $0.03 | – | +1.13% | −4.5% | −4.5% |
| Feb 1, 2011 | After close | Q4 2010 | $0.15 | – | −3.93% | −3.5% | +2.5% |
| Oct 19, 2010 | After close | Q3 2010 | $0.12 | – | +5.53% | −3.4% | +8.6% |
| Jul 20, 2010 | After close | Q2 2010 | $0.06 | −40% | −4.78% | +3.6% | −6.7% |
| Apr 26, 2010 | After close | Q1 2010 | $-1.05 | – | +0.57% | −2.1% | −5.8% |
| Feb 10, 2010 | After close | Q4 2009 | $-0.71 | – | −9.89% | −12.6% | +5.6% |
| Oct 19, 2009 | After close | Q3 2009 | $-0.06 | – | −15.65% | −6.0% | −3.5% |
| Jul 20, 2009 | After close | Q2 2009 | $0.10 | +43% | +0.19% | −1.2% | +6.9% |
| Apr 15, 2009 | After close | Q1 2009 | $-0.01 | – | −0.33% | +10.9% | −2.9% |
| Jan 29, 2009 | Before open | Q4 2008 | – | – | +3.06% | +6.4% | −6.6% |
| Oct 14, 2008 | After close | Q3 2008 | $-0.04 | – | −5.91% | −25.3% | +0.2% |
| Jul 21, 2008 | After close | Q2 2008 | $0.07 | – | −11.01% | +12.8% | +7.7% |
| Apr 21, 2008 | After close | Q1 2008 | – | – | −1.00% | +1.2% | +0.9% |
| Feb 4, 2008 | After close | Q4 2007 | – | – | −0.62% | +9.5% | +1.8% |
| Oct 19, 2007 | Before open | Q3 2007 | – | – | +4.12% | −0.5% | −12.2% |
| Jul 20, 2007 | Before open | Q2 2007 | – | – | −2.50% | −1.9% | −11.6% |
| Apr 23, 2007 | After close | Q1 2007 | – | – | −1.55% | +10.7% | −1.6% |
| Feb 1, 2007 | Before open | Q4 2006 | – | – | −0.65% | +4.8% | −6.6% |
| Oct 18, 2006 | After close | Q3 2006 | – | – | +5.81% | +2.2% | +0.3% |
| Jul 27, 2006 | Before open | Q2 2006 | – | – | +4.04% | +5.4% | −5.2% |
| Apr 18, 2006 | Intraday | Q1 2006 | – | – | +1.21% | −8.6% | −1.8% |
| Feb 7, 2006 | Before open | Q4 2005 | – | – | +2.96% | −14.2% | +7.8% |
| Oct 14, 2005 | Before open | Q3 2005 | – | – | −1.81% | +2.1% | +7.1% |
| Jul 19, 2005 | Intraday | Q2 2005 | – | – | +4.23% | −1.2% | +1.8% |
| Apr 19, 2005 | Intraday | Q1 2005 | – | – | −5.53% | +6.4% | +2.4% |
| Feb 1, 2005 | Before open | Q4 2004 | – | – | +5.29% | −4.8% | −7.4% |
| Oct 19, 2004 | Before open | Q3 2004 | – | – | −7.04% | −0.5% | +2.9% |
* Q4 EPS derived from the annual figure minus the first three quarters. EPS as reported by the company; not adjusted for later stock splits.
Where the revenue comes from · as reported to the SEC
BSX reports its revenue by 8 product and service lines, 2 business segments and 2 regions. Latest: $5.1B in the quarter ending Sep 2026, +1% from a year earlier.
Figures are from BSX’s own 10-Q and 10-K financial statements (XBRL), as reported, not adjusted. Products, segments and regions are the company’s own groupings and can change when it reorganises; only periods comparable with the latest are shown. * Fourth quarter = fiscal year minus the first nine months.
BSX revenue by product and service
In the quarter ending Sep 2026, Interventional Cardiology & Vascular Therapies brought in $1.3B, 25% of BSX’s $5.1B revenue. Compared with a year earlier, Neuromodulation grew fastest (+13%) and Watchman shrank most (−6%).
| Quarter ending | Mar ’25 | Jun ’25 | Sep ’25 | Mar ’26 | Jun ’26 | Sep ’26 | Share | vs year before |
|---|---|---|---|---|---|---|---|---|
| Interventional Cardiology & Vascular Therapies | $1.1B | $1.2B | $1.1B | $1.2B | $1.3B | $1.3B | 25% | +12% |
| Electrophysiology | $730M | $840M | $865M | $905M | $916M | $816M | 16% | −6% |
| Endoscopy | $673M | $737M | $747M | $736M | $793M | $741M | 14% | −1% |
| Urology | $633M | $676M | $682M | $646M | $684M | $661M | 13% | −3% |
| Cardiac Rhythm Management | $578M | $590M | $578M | $578M | $585M | $568M | 11% | −2% |
| Watchman | $425M | $486M | $512M | $506M | $507M | $482M | 9% | −6% |
| Neuromodulation | $271M | $303M | $293M | $318M | $341M | $331M | 6% | +13% |
| Interventional Oncology & Embolization | $228M | $251M | $253M | $268M | $283M | $267M | 5% | +6% |
| Total revenue | $4.7B | $5.1B | $5.1B | $5.2B | $5.4B | $5.1B | 100% | +1% |
Fiscal years
| Fiscal year ending | Dec ’23 | Dec ’24 | Dec ’25 | Share | vs year before |
|---|---|---|---|---|---|
| Interventional Cardiology Vascular Therapies | $3.8B | $4.2B | $4.6B | 23% | +10% |
| Electrophysiology | $800M | $1.9B | $3.3B | 17% | +75% |
| Endoscopy | $2.5B | $2.7B | $2.9B | 15% | +9% |
| Urology | $2.0B | $2.2B | $2.7B | 13% | +23% |
| Cardiac Rhythm Management | $2.2B | $2.3B | $2.3B | 12% | +2% |
| Watchman | $1.3B | $1.5B | $2.0B | 10% | +29% |
| Neuromodulation | $976M | $1.1B | $1.2B | 6% | +8% |
| Interventional Oncology Embolization | $736M | $856M | $996M | 5% | +16% |
| Total revenue | $14.2B | $16.7B | $20.1B | 100% | +20% |
BSX revenue by business segment
In the quarter ending Sep 2026, Cardiovascular brought in $3.4B, 66% of BSX’s $5.1B revenue. Compared with a year earlier, Cardiovascular changed +2% and MedSurg +1%.
| Quarter ending | Dec ’24* | Mar ’25 | Jun ’25 | Sep ’25 | Dec ’25* | Mar ’26 | Jun ’26 | Sep ’26 | Share | vs year before |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | $2.9B | $3.1B | $3.3B | $3.3B | $3.5B | $3.5B | $3.6B | $3.4B | 66% | +2% |
| MedSurg | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B | $1.7B | $1.8B | $1.7B | 34% | +1% |
| Total revenue | $4.6B | $4.7B | $5.1B | $5.1B | $5.3B | $5.2B | $5.4B | $5.1B | 100% | +1% |
Fiscal years
| Fiscal year ending | Dec ’22 | Dec ’23 | Dec ’24 | Dec ’25 | Share | vs year before |
|---|---|---|---|---|---|---|
| Cardiovascular | $7.8B | $8.8B | $10.8B | $13.3B | 66% | +23% |
| MedSurg | $4.9B | $5.4B | $6.0B | $6.8B | 34% | +14% |
| Total revenue | $12.7B | $14.2B | $16.7B | $20.1B | 100% | +20% |
BSX revenue by region
In the quarter ending Sep 2026, United States brought in $3.3B, 64% of BSX’s $5.1B revenue. Compared with a year earlier, Outside the U.S. changed +3% and United States +0%.
| Quarter ending | Jun ’24 | Sep ’24 | Mar ’25 | Jun ’25 | Sep ’25 | Mar ’26 | Jun ’26 | Sep ’26 | Share | vs year before |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $2.5B | $2.6B | $3.0B | $3.2B | $3.3B | $3.3B | $3.4B | $3.3B | 64% | +0% |
| Outside the U.S. | $1.7B | $1.6B | $1.7B | $1.8B | $1.8B | $1.9B | $2.0B | $1.8B | 36% | +3% |
| Total revenue | $4.1B | $4.2B | $4.7B | $5.1B | $5.1B | $5.2B | $5.4B | $5.1B | 100% | +1% |
Fiscal years
| Fiscal year ending | Dec ’21 | Dec ’23 | Dec ’24 | Dec ’25 | Share | vs year before |
|---|---|---|---|---|---|---|
| United States | $6.9B | $8.4B | $10.2B | $12.9B | 64% | +26% |
| Europe, Middle East and Africa | $2.5B | $2.9B | $3.2B | $3.5B | 17% | +7% |
| Asia-Pacific | $2.1B | $2.4B | $2.7B | $3.1B | 15% | +15% |
| Latin America and Canada | $386M | $560M | $624M | $678M | 3% | +9% |
| Total revenue | $11.9B | $14.2B | $16.7B | $20.1B | 100% | +20% |
Company events · from 309 SEC 8-K filings since 2004
In the last five years BSX filed 48 event reports, including 1 major events, 6 deals, 1 restructuring & write-downs, 20 leadership. On the days after major events (deals completed, restructurings, write-downs and similar) the stock moved 3.6% on average in either direction, against 1.2% on a typical day. Latest major event: cybersecurity incident on September 8, 2026 (−5.9% the next session).
From the item codes companies must use when filing a Form 8-K with the SEC. Under each event type is a one-line extract of what the filing says, picked out of the filing text automatically (not written or checked by an editor); open the filing for the full wording. Quarterly earnings releases are in the section above.
| Filed | Event | Next-session move | Source |
|---|---|---|---|
| Executive or board change · Other company newsBoston Scientific Corporation announced that Joe Fitzgerald, who currently serves as Executive Vice President and Group President, Cardiovascular, has been promoted to Executive Vice President and Chief Operating Officer of the Company… | −1.45% | SEC filing | |
| Executive or board changeArthur C. Butcher informed Boston Scientific Corporation that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January 1, 2027. | −0.67% | SEC filing | |
| Cybersecurity incident2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation identified a cybersecurity incident that affected certain of its information technology systems and resulted in a global disruption to… | −5.90% | SEC filing | |
| Other company newsBoston Scientific Corporation identified a cybersecurity incident affecting certain of its information technology systems that has resulted in a global disruption to the Company’s operations. | −3.39% | SEC filing | |
| Restructuring, closures or layoffs (exit costs)The Board of Directors of Boston Scientific Corporation approved a new global restructuring program. | +1.21% | SEC filing | |
| Other company newsAnnounced that the Company has entered into an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association for $2 billion of its common stock, as part of its previously announced $5 billion share repurchase… | +6.15% | SEC filing | |
| Other company newsAnnounced that the Company has entered into an investment agreement with MiRus LLC, a privately held company developing and commercializing proprietary novel biomaterials, implants and procedural solutions for the treatment of… | +6.15% | SEC filing | |
| Bylaws or fiscal year change · Shareholder vote resultsThe stockholders of Boston Scientific Corporation, at the Company’s 2026 Annual Meeting of Stockholders, approved amendments to the Company’s Third Restated Certificate of Incorporation, as described in the Company’s definitive proxy… | +0.04% | SEC filing | |
| Other company newsAnnounced results from the Company's HI-PEITHO clinical trial. Also on March 28, 2026, the Company issued a second press release announcing results from the Company's CHAMPION-AF clinical trial. | −9.02% | SEC filing | |
| Signed a material agreement · Ended a material agreement · New debt or financingBoston Scientific Corporation entered into a $3.000 billion revolving credit agreement by and among the Company, as borrower, the several lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent. | +1.45% | SEC filing | |
| Executive or board change · Investor presentation or announcement · Other company newsThe Board of Directors of Boston Scientific Corporation, upon the recommendation of the Nominating and Governance Committee of the Board, increased the number of directors comprising the Board from ten to twelve, and appointed each of… | +1.05% | SEC filing | |
| Executive or board changeYoshiaki Fujimori informed Boston Scientific Corporation that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders. | −1.76% | SEC filing | |
| Signed a material agreementBoston Scientific Corporation entered into an Agreement and Plan of Merger with Pinehurst Merger Sub, Inc. and Penumbra, Inc. providing for the merger of Merger Sub with and into Penumbra, with Penumbra surviving the Merger as a wholly… | −2.18% | SEC filing | |
| Investor presentation or announcementAnnounced that the Company, Pinehurst Merger Sub, Inc. and Penumbra have executed a definitive agreement pursuant to which the Company agreed to acquire Penumbra on the terms and subject to the conditions set forth in the definitive… | −3.96% | SEC filing | |
| Executive or board changeUpon the recommendation of the Executive Compensation and Human Resources Committee, the Board of Directors of Boston Scientific Corporation approved the Company’s 2026 Annual Bonus Plan effective for the performance year of January 1… | −0.42% | SEC filing | |
| Executive or board changeJohn E. Sununu informed Boston Scientific Corporation that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders. | −1.25% | SEC filing | |
| Executive or board changeJeffrey B. Mirviss informed Boston Scientific Corporation that he has decided to retire from his role as Executive Vice President and President, Peripheral Interventions effective as of December 1, 2025. | −0.07% | SEC filing | |
| Other company newsBoston Scientific Corporation announced it is discontinuing worldwide sales of the ACURATE neo2™ and ACURATE Prime™ Aortic Valve Systems and no longer pursuing U.S. FDA approval for ACURATE or approval in other geographies. | −1.56% | SEC filing | |
| Shareholder vote resultsBoston Scientific Corporation held its 2025 Annual Meeting of Stockholders on May 1, 2025, in a virtual format via live webcast. | +0.65% | SEC filing | |
| Executive or board change · Other company newsBoston Scientific Corporation announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025, and that Jonathan Monson, who… | +4.07% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company newsBoston Scientific Corporation, as guarantor, and American Medical Systems Europe B.V., its wholly owned finance subsidiary, as issuer, entered into an Underwriting Agreement, among the Company, AMS Europe and the several underwriters… | −0.75% | SEC filing | |
| Executive or board changeCharles J. Dockendorff informed Boston Scientific Corporation that he will not stand for re-election at the Company’s 2025 Annual Meeting of Stockholders. | +0.35% | SEC filing | |
| Other company newsThe United States District Court for the District of Massachusetts issued an order granting preliminary approval to a proposed settlement of two shareholder derivative actions and demands for access to certain books and records of Boston… | +0.50% | SEC filing | |
| Executive or board changeUpon the recommendation of the Executive Compensation and Human Resources Committee, the Board of Directors of Boston Scientific Corporation approved the Company’s 2025 Annual Bonus Plan effective for the performance year of January 1… | −0.83% | SEC filing | |
| Other company newsBoston Scientific Corporation completed its acquisition of Axonics, Inc., a public medical technology company focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction. | +3.98% | SEC filing | |
| Investor presentation or announcementBoston Scientific Corporation announced that it is resuming the AVANT GUARD clinical trial studying a new population of drug-naïve patients with persistent atrial fibrillation. | +0.51% | SEC filing | |
| Executive or board change · Investor presentation or announcementHabiger, to be a director of the Company, to hold office until the next annual meeting of stockholders, effective July 30, 2024. The Board further appointed Mr. Habiger to serve as a member of the Audit Committee and the Executive… | −0.20% | SEC filing | |
| Executive or board change · Bylaws or fiscal year change · Investor presentation or announcement · Other company newsThe Board further appointed Dr. Pegus to serve as a member of the Executive Compensation and Human Resources Committee and the Risk Committee of the Board. | −1.19% | SEC filing | |
| Bylaws or fiscal year change · Shareholder vote resultsIn February 2024, the Board of Directors of Boston Scientific Corporation voted unanimously to approve, subject to stockholder approval, and to recommend to the Company’s stockholders that they approve, an amendment and restatement of… | +1.21% | SEC filing | |
| Other company newsBoston Scientific Corporation entered into an Agreement and Plan of Merger with Sadie Merger Sub, Inc. and Axonics, Inc. providing for the merger of Merger Sub with and into Axonics, with Axonics surviving the Merger as a wholly owned… | −0.56% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company newsBoston Scientific Corporation, as guarantor, and American Medical Systems Europe B.V., its wholly owned finance subsidiary, as issuer, entered into an Underwriting Agreement, among the Company, AMS Europe and the several underwriters… | +0.84% | SEC filing | |
| Executive or board changeMr. Monson currently serves as Senior Vice President, Global Controller and Chief Accounting Officer, a position he has held since July 2019; effective March 1, 2024, Mr. Monson will no longer serve as the Company’s Chief Accounting Officer. | +2.47% | SEC filing | |
| Signed a material agreementBoston Scientific Corporation entered into an Agreement and Plan of Merger with Sadie Merger Sub, Inc. and Axonics, Inc. providing for the merger of Merger Sub with and into Axonics, with Axonics surviving the Merger as a wholly owned… | +1.39% | SEC filing | |
| Investor presentation or announcementAnnounced that the Company and Axonics, Inc. have executed a definitive agreement pursuant to which the Company agreed to acquire Axonics on the terms and subject to the conditions set forth in the definitive agreement. | +0.45% | SEC filing | |
| Executive or board changeNelda J. Connors informed Boston Scientific Corporation that she will not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders. | +0.36% | SEC filing | |
| Executive or board change · Investor presentation or announcement | −0.07% | SEC filing | |
| Other company news | +0.06% | SEC filing | |
| Shareholder vote results | +0.24% | SEC filing | |
| Other company news | +0.92% | SEC filing | |
| Executive or board change | +2.79% | SEC filing | |
| Executive or board change | +1.40% | SEC filing | |
| Executive or board change · Shareholder vote results | −6.27% | SEC filing | |
| Executive or board change | +0.52% | SEC filing | |
| Other company news | +0.02% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company news | +2.86% | SEC filing | |
| Investor presentation or announcement | +1.25% | SEC filing | |
| Other company news | +0.41% | SEC filing | |
| Executive or board change | +1.17% | SEC filing | |
| Other company news | −0.79% | SEC filing | |
| Other company news | +1.77% | SEC filing | |
| Other company news | +2.19% | SEC filing | |
| Other company news | +0.95% | SEC filing | |
| Executive or board change · Investor presentation or announcement | +0.89% | SEC filing | |
| Other company news | +0.89% | SEC filing | |
| Signed a material agreement · Ended a material agreement · New debt or financing | −0.14% | SEC filing | |
| Shareholder vote results | −2.77% | SEC filing | |
| Executive or board change | +0.52% | SEC filing | |
| Other company news | +0.15% | SEC filing | |
| Other company news | −0.36% | SEC filing | |
| Other company news | +2.35% | SEC filing | |
| Results update | −3.05% | SEC filing | |
| Other company news | +3.65% | SEC filing | |
| Restructuring, closures or layoffs (exit costs) · Other company news | +1.51% | SEC filing | |
| Executive or board change | −0.71% | SEC filing | |
| Restructuring, closures or layoffs (exit costs) · Other company news | −2.20% | SEC filing | |
| Executive or board change | +0.23% | SEC filing | |
| Executive or board change | −2.24% | SEC filing | |
| Executive or board change | −2.17% | SEC filing | |
| Signed a material agreement | −1.29% | SEC filing | |
| Signed a material agreement · Change to shareholder rights · Bylaws or fiscal year change · Other company news | +0.89% | SEC filing | |
| Other company news | +3.22% | SEC filing | |
| Signed a material agreement · Other company news | −2.72% | SEC filing | |
| Other company news | −1.89% | SEC filing | |
| Executive or board change · Shareholder vote results | −3.27% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company news | +1.26% | SEC filing | |
| Other company news | −4.40% | SEC filing | |
| Results update · Executive or board change · Investor presentation or announcement | +2.85% | SEC filing | |
| Results update | +3.36% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company news | −1.40% | SEC filing | |
| Results update | −0.61% | SEC filing | |
| Other company news | −0.61% | SEC filing | |
| Other company news | +0.20% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company news | +1.90% | SEC filing | |
| Other company news | −0.05% | SEC filing | |
| Executive or board change | −0.59% | SEC filing | |
| Signed a material agreement · Other company news | +0.49% | SEC filing | |
| Other company news | 0.00% | SEC filing | |
| Investor presentation or announcement | −1.22% | SEC filing | |
| New debt or financing · Other company news | +1.40% | SEC filing | |
| Other company news | +1.06% | SEC filing | |
| Other company news | −0.35% | SEC filing | |
| Other company news | −0.49% | SEC filing | |
| Other company news | −0.90% | SEC filing | |
| Executive or board change · Bylaws or fiscal year change · Shareholder vote results | +1.48% | SEC filing | |
| Other company news | −1.32% | SEC filing | |
| Investor presentation or announcement | −3.48% | SEC filing | |
| Other company news | +1.57% | SEC filing | |
| Signed a material agreement · Investor presentation or announcement · Other company news | −0.33% | SEC filing | |
| Other company news | +1.00% | SEC filing | |
| Other company news | +0.23% | SEC filing | |
| Other company news | +1.11% | SEC filing | |
| Results update | +2.79% | SEC filing | |
| Other company news | +2.38% | SEC filing | |
| Signed a material agreement · Ended a material agreement · New debt or financing | −3.35% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company news | +0.58% | SEC filing | |
| Executive or board change | −3.51% | SEC filing | |
| Restructuring, closures or layoffs (exit costs) | +2.03% | SEC filing | |
| Other company news | +0.83% | SEC filing | |
| Signed a material agreement · New debt or financing | −0.23% | SEC filing | |
| Investor presentation or announcement | +3.22% | SEC filing | |
| Investor presentation or announcement | +2.23% | SEC filing | |
| Investor presentation or announcement | +7.42% | SEC filing | |
| Other company news | −0.39% | SEC filing | |
| Shareholder vote results | −0.37% | SEC filing | |
| Other company news | −2.38% | SEC filing | |
| Signed a material agreement · Investor presentation or announcement · Other company news | −0.62% | SEC filing | |
| Other company news | +2.72% | SEC filing | |
| Results update | +8.33% | SEC filing | |
| Executive or board change | −0.79% | SEC filing | |
| Other company news | −1.67% | SEC filing | |
| Executive or board change | +0.32% | SEC filing | |
| Other company news | +0.55% | SEC filing | |
| Signed a material agreement · Ended a material agreement · New debt or financing | −0.93% | SEC filing | |
| Shareholder vote results | −0.53% | SEC filing | |
| Executive or board change | +1.39% | SEC filing | |
| Other company news | −1.05% | SEC filing | |
| Other company news | −2.70% | SEC filing | |
| Signed a material agreement · New debt or financing | +0.40% | SEC filing | |
| Executive or board change | −0.92% | SEC filing | |
| Executive or board change | +0.67% | SEC filing | |
| Other company news | −0.04% | SEC filing | |
| Executive or board change | −0.25% | SEC filing | |
| Other company news | +2.15% | SEC filing | |
| Executive or board change | −0.04% | SEC filing | |
| Restructuring, closures or layoffs (exit costs) · Investor presentation or announcement | +2.28% | SEC filing | |
| Shareholder vote results | +1.06% | SEC filing | |
| Executive or board change · Other company news | −0.06% | SEC filing | |
| Executive or board change | −2.93% | SEC filing | |
| Other company news | −0.12% | SEC filing | |
| Executive or board change | −0.89% | SEC filing | |
| Signed a material agreement · Investor presentation or announcement · Other company news | −1.14% | SEC filing | |
| Other company news | +1.92% | SEC filing | |
| Shareholder vote results | −0.69% | SEC filing | |
| Investor presentation or announcement | −0.45% | SEC filing | |
| Signed a material agreement · Ended a material agreement · New debt or financing · Other company news | +0.78% | SEC filing | |
| Executive or board change | +0.18% | SEC filing | |
| Signed a material agreement · Other company news | +0.95% | SEC filing | |
| Signed a material agreement · Results update · Other company news | +12.40% | SEC filing | |
| Executive or board change | +2.41% | SEC filing | |
| Executive or board change | +0.76% | SEC filing | |
| Executive or board change | +0.68% | SEC filing | |
| Other company news | −1.65% | SEC filing | |
| Other company news | −0.78% | SEC filing | |
| Shareholder vote results | −0.55% | SEC filing | |
| Executive or board change | +1.77% | SEC filing | |
| Executive or board change | +0.09% | SEC filing | |
| Executive or board change | −0.34% | SEC filing | |
| Executive or board change · Other company news | −6.10% | SEC filing | |
| Restructuring, closures or layoffs (exit costs) | −6.10% | SEC filing | |
| Signed a material agreement · Investor presentation or announcement · Other company news | +0.36% | SEC filing | |
| Other company news | +0.27% | SEC filing | |
| Other company news | −2.13% | SEC filing | |
| Other company news | +0.54% | SEC filing | |
| Other company news | −0.65% | SEC filing | |
| Shareholder vote results | +1.81% | SEC filing | |
| Executive or board change | −1.20% | SEC filing | |
| Other company news | +0.38% | SEC filing | |
| Executive or board change · Other company news | +1.95% | SEC filing | |
| Other company news | −0.54% | SEC filing | |
| Impairment (write-down) | +5.03% | SEC filing | |
| Signed a material agreement · New debt or financing | −0.53% | SEC filing | |
| Shareholder vote results | −1.44% | SEC filing | |
| Signed a material agreement · Ended a material agreement · New debt or financing | +1.54% | SEC filing | |
| Other company news | +0.34% | SEC filing | |
| Executive or board change | −2.67% | SEC filing | |
| Executive or board change | −0.97% | SEC filing | |
| Other company news | −4.83% | SEC filing | |
| Other company news | +0.19% | SEC filing | |
| Executive or board change | +3.57% | SEC filing | |
| Executive or board change · Bylaws or fiscal year change · Other company news | −1.27% | SEC filing | |
| Other company news | +0.64% | SEC filing | |
| Executive or board change | −4.05% | SEC filing | |
| Executive or board change | +0.15% | SEC filing | |
| Executive or board change | −8.95% | SEC filing | |
| Executive or board change | −0.80% | SEC filing | |
| Other company news | +1.71% | SEC filing | |
| Other company news | −2.46% | SEC filing | |
| Executive or board change | +0.80% | SEC filing | |
| Results update · Other company news | +1.51% | SEC filing | |
| Other company news | +0.40% | SEC filing | |
| Other company news | +0.38% | SEC filing | |
| Executive or board change | +0.38% | SEC filing | |
| Other company news | +3.20% | SEC filing | |
| Executive or board change | +1.90% | SEC filing | |
| Signed a material agreement · Other company news | +1.11% | SEC filing | |
| Other company news | +2.21% | SEC filing | |
| Other company news | −4.62% | SEC filing | |
| Signed a material agreement · Ended a material agreement · New debt or financing · Other company news | −1.32% | SEC filing | |
| Other company news | −1.58% | SEC filing | |
| Executive or board change · Shareholder vote results · Other company news | −1.76% | SEC filing | |
| Other company news | −1.55% | SEC filing | |
| Executive or board change | −2.08% | SEC filing | |
| Other company news | +2.80% | SEC filing | |
| Investor presentation or announcement | +2.57% | SEC filing | |
| Other company news | −12.60% | SEC filing | |
| Executive or board change | +0.64% | SEC filing | |
| Signed a material agreement | −0.24% | SEC filing | |
| Other company news | +0.34% | SEC filing | |
| Executive or board change | −0.34% | SEC filing | |
| Signed a material agreement · New debt or financing · Other company news | −0.78% | SEC filing | |
| Other company news | −0.57% | SEC filing | |
| Other company news | +2.83% | SEC filing | |
| Other company news | +2.83% | SEC filing | |
| Results update | +0.37% | SEC filing | |
| Executive or board change | +0.37% | SEC filing | |
| Executive or board change | −2.68% | SEC filing | |
| Other company news | +1.10% | SEC filing | |
| Executive or board change | +0.47% | SEC filing | |
| Executive or board change | +5.15% | SEC filing | |
| Executive or board change | +1.34% | SEC filing | |
| Results update | −2.76% | SEC filing | |
| Other company news | +6.48% | SEC filing | |
| Executive or board change | +3.20% | SEC filing | |
| Executive or board change | −8.37% | SEC filing | |
| Executive or board change | +2.11% | SEC filing | |
| Signed a material agreement · Results update | −5.65% | SEC filing | |
| Other company news | +4.79% | SEC filing | |
| Signed a material agreement · Executive or board change | −2.12% | SEC filing | |
| Signed a material agreement | −2.10% | SEC filing | |
| Results update | −4.99% | SEC filing | |
| Impairment (write-down) · Results update · Other company news | −6.26% | SEC filing | |
| Signed a material agreement · Executive or board change | +1.42% | SEC filing | |
| Impairment (write-down) | −2.21% | SEC filing | |
| Executive or board change | +2.21% | SEC filing | |
| Other company news | +0.84% | SEC filing | |
| Executive or board change | +1.27% | SEC filing | |
| Signed a material agreement | +1.94% | SEC filing | |
| Executive or board change | +0.48% | SEC filing | |
| Executive or board change | −0.47% | SEC filing | |
| Signed a material agreement | +0.08% | SEC filing | |
| Other company news | +6.56% | SEC filing | |
| Signed a material agreement | +6.56% | SEC filing | |
| Signed a material agreement | +2.07% | SEC filing | |
| Other company news | +1.39% | SEC filing | |
| Signed a material agreement | +2.21% | SEC filing | |
| Signed a material agreement | −4.57% | SEC filing | |
| Signed a material agreement · Executive or board change | −0.30% | SEC filing | |
| Executive or board change | +0.99% | SEC filing | |
| Signed a material agreement | +1.92% | SEC filing | |
| Restructuring, closures or layoffs (exit costs) · Impairment (write-down) · Signed a material agreement | −0.92% | SEC filing | |
| Signed a material agreement · Other company news | −2.53% | SEC filing | |
| Other company news | +0.58% | SEC filing | |
| Bylaws or fiscal year change | −1.64% | SEC filing | |
| Executive or board change | −0.54% | SEC filing | |
| Executive or board change · Other company news | +3.95% | SEC filing | |
| Other company news | −0.53% | SEC filing | |
| Investor presentation or announcement | +1.23% | SEC filing | |
| Executive or board change | −4.65% | SEC filing | |
| Results update · Investor presentation or announcement | +1.18% | SEC filing | |
| Restructuring, closures or layoffs (exit costs) | −1.18% | SEC filing | |
| Signed a material agreement | +4.15% | SEC filing | |
| Signed a material agreement | −1.48% | SEC filing | |
| Investor presentation or announcement | −9.23% | SEC filing | |
| Signed a material agreement | +2.09% | SEC filing | |
| Signed a material agreement | +4.04% | SEC filing | |
| Signed a material agreement | +1.87% | SEC filing | |
| Other company news | +1.80% | SEC filing | |
| Signed a material agreement · Other company news | −1.52% | SEC filing | |
| Signed a material agreement | −2.68% | SEC filing | |
| Completed an acquisition or sale of assets · Signed a material agreement · New debt or financing · Change to shareholder rights | +1.04% | SEC filing | |
| Executive or board change | +2.76% | SEC filing | |
| Other company news | +2.16% | SEC filing | |
| Other company news | +3.75% | SEC filing | |
| Signed a material agreement · Other company news | −0.19% | SEC filing | |
| Other company news | −1.82% | SEC filing | |
| Signed a material agreement | +3.89% | SEC filing | |
| Other company news | +0.53% | SEC filing | |
| Other company news | −1.96% | SEC filing | |
| Other company news | −1.13% | SEC filing | |
| Signed a material agreement | −6.57% | SEC filing | |
| Other company news | −1.92% | SEC filing | |
| Other company news | −5.16% | SEC filing | |
| Other company news | +0.60% | SEC filing | |
| Other company news | +2.32% | SEC filing | |
| Signed a material agreement | −0.12% | SEC filing | |
| Other company news | −3.59% | SEC filing | |
| Signed a material agreement · Other company news | +0.62% | SEC filing | |
| Other company news | +0.24% | SEC filing | |
| Signed a material agreement | +2.16% | SEC filing | |
| Signed a material agreement | −3.16% | SEC filing | |
| Signed a material agreement | +0.32% | SEC filing | |
| Other company news | 0.00% | SEC filing | |
| Signed a material agreement | 0.00% | SEC filing | |
| Signed a material agreement | −2.10% | SEC filing | |
| Other company news | −1.78% | SEC filing | |
| Other company news | +0.04% | SEC filing | |
| Signed a material agreement | +0.22% | SEC filing | |
| Signed a material agreement | +1.49% | SEC filing | |
| Signed a material agreement | −1.61% | SEC filing | |
| Signed a material agreement | +2.16% | SEC filing | |
| Results update | −1.32% | SEC filing | |
| Signed a material agreement · Other company news | −0.22% | SEC filing | |
| Executive or board change | +1.01% | SEC filing | |
| Signed a material agreement | +2.16% | SEC filing | |
| Signed a material agreement | +0.72% | SEC filing | |
| Signed a material agreement · Other company news | +0.53% | SEC filing | |
| Signed a material agreement | −2.51% | SEC filing | |
| Other company news | −2.51% | SEC filing | |
| Signed a material agreement | −0.68% | SEC filing |
BSX price history and multi-year cycles
Daily percent change, May 19, 1992 to November 13, 2026
Close is plotted by default. Add open, high, low or volume from the legend, and drag across the chart to zoom into any period.
Stock market cycle · 33 complete years, monthly closes since May 1992
No reliable multi-year cycle. The strongest repeating swing around BSX's long-term trend lasts about 6.8 years from peak to peak, moving the price roughly ±21% around the trend and explaining 22% of the swings. Random price wandering with the same persistence produces a cycle at least that strong in ~19% of simulations, so it could easily be chance.
Using swings of 28% or more (scaled to its volatility of 35% a year), BSX made 11 major peaks and 10 major troughs. Peaks came every 2.7 years (median; range 0.5–9.0), troughs every 1.8 years. The spacing is irregular, so the gaps are not a reliable clock. Typical drawdown: −40% over 8 months; typical recovery to the next peak: 9 months.
Latest major turning point: a peak in Jun 2025, 17 months ago; the price has moved −59% since and is −59% from its all-time high.
6 of its 10 major drawdowns overlapped a broad S&P 500 sell-off or bear market (within three months), so most of its down-cycles were market-wide. Its swings around trend move only loosely with the Dow's (correlation 0.13 over 35 years); the Dow's own strongest cycle is about 3.5 years. Calendar-year returns show no meaningful year-to-year memory: one year's result has said little about the next.
Since 2009, reported EPS was below the year-earlier quarter in 20 of 54 quarters. Earnings down-cycles of two or more quarters began in Oct 2009 (3 quarters, price −41%), Jul 2012 (3 quarters, price +41%), Jul 2019 (5 quarters, price −21%). They started every 4.9 years (median).
Computed from monthly closes (not adjusted for dividends): trend = 10-year local regression of log price; cycle = best sine fit from 2 to 8 years, tested against 120 red-noise simulations; turning points use a volatility-scaled reversal threshold; EPS from SEC filings. Past cycles do not predict future prices; this is not investment advice.
BSX stock cycle: price vs long-term trend, with major peaks and troughs
The blue line is how far the monthly close sat above (+) or below (−) its 10-year trend; triangles mark the major turning points; grey bands are S&P 500 bear markets and crashes. Drag the panel below the chart to zoom.
| Term year | Years | Average return | Up years | Dow, same years |
|---|---|---|---|---|
| Post-election year | 9 | +16.4% | 6 of 9 | +14.5% |
| Midterm year | 8 | +18.5% | 6 of 8 | +2.7% |
| Pre-election year | 8 | +33.6% | 5 of 8 | +16.2% |
| Election year | 8 | +0.8% | 4 of 8 | +3.7% |
Show all 10 drawdowns and recoveries (peak to trough)
| Peak | Trough | Drawdown | Months down | Recovery to next peak | Months up | During S&P 500 sell-off |
|---|---|---|---|---|---|---|
| Dec 2019 | Mar 2020 | −28% | 3 | +229% | 63 | Yes |
| Dec 2010 | Oct 2012 | −32% | 22 | +780% | 86 | Yes |
| Aug 2009 | Aug 2010 | −56% | 12 | +46% | 4 | No |
| May 2004 | Nov 2008 | −86% | 54 | +90% | 9 | Yes |
| Apr 2000 | Nov 2000 | −51% | 7 | +588% | 42 | Yes |
| Jun 1999 | Feb 2000 | −58% | 8 | +45% | 2 | Yes |
| Jul 1998 | Jan 1999 | −36% | 6 | +80% | 5 | Yes |
| Jul 1997 | Nov 1997 | −37% | 4 | +70% | 8 | No |
| Jan 1997 | Apr 1997 | −29% | 3 | +49% | 3 | No |
| May 1992 | Sep 1993 | −44% | 16 | +566% | 40 | No |
What if you had traded BSX by simple rules?
$10,000 in BSX · January 2015 to Nov 13, 2026
Trading hours vs overnight
Most of BSX's gains came overnight: owning it only from open to close turned $10,000 into $9,187, owning it only from close to the next open into $36,318. Together they make up buy and hold ($33,540).
Did the seasonal signal help? No clear edge
Average open-to-close move: +0.019% on the 721 days when all three methods pointed up, +0.007% on all days, −0.009% on the 534 down-signal days. Holding from the previous close to the next open: +0.11% around up-signal days (no different from any day).
Hypothetical results from daily open and close prices since January 2015 (earlier prices are rounded too coarsely for open-based tests), price only: dividends are not added back, and because a stock drops by its dividend at the open on the ex-dividend date, overnight results of dividend payers are understated by roughly their dividend yield; no taxes. The "after costs" column deducts 0.05% per trade; real spreads, commissions and slippage can be larger, which matters most for daily rules. Seasonal signals use only data from years before each trade. Past results do not predict future results. Study: these rules across 293 stocks and ETFs.
| Rule | $10,000 became | Per year | Last 10 yrs, per year | Trades | Winning trades | Average trade | Worst drawdown | After 0.05% per trade |
|---|---|---|---|---|---|---|---|---|
| Open to close, every dayBuy at each open, sell at the same day's close (trading hours only) | $9,187 | −0.7% | −2.5% | 2,985 | 51% | +0.01% | −62% | $2,064 |
| Close to next open, every dayBuy at each close, sell at the next open (overnight only) | $36,318 | +11.5% | +10.7% | 2,984 | 52% | +0.05% | −36% | $8,166 |
| Open to next openBuy at the open, sell at the next session's open | $33,627 | +10.8% | +7.6% | 2,984 | 52% | +0.06% | −62% | $7,561 |
| Close to close (buy and hold)Buy at the close, sell at the next close: the same as holding | $33,540 | +10.7% | +7.9% | 2,984 | 52% | +0.06% | −62% | $7,541 |
| Each week, open to closeBuy the week's first open, sell its last close (out over weekends) | $37,432 | +11.8% | +8.7% | 620 | 55% | +0.27% | −56% | $27,452 |
| Each month, open to closeBuy the month's first open, sell its last close | $26,900 | +8.7% | +5.7% | 143 | 57% | +0.92% | −63% | $25,044 |
| Each year, open to closeBuy the year's first open, sell its last close | $72,192 | +18.1% | +15.9% | 11 | 91% | +21.39% | −21% | $71,796 |
| Up-signal days, open to closeOn each day when all three seasonal methods point up: buy at that day's open, sell at its close. Otherwise in cash. | $10,600 | +0.5% | −2.1% | 721 | 51% | +0.02% | −41% | $7,391 |
| Up-signal days, close before to open afterBuy at the close the day before an up-signal day, sell at the open the day after it. Back-to-back signal days are held as one trade. | $13,561 | +2.6% | +0.3% | 506 | 52% | +0.09% | −61% | $10,529 |
| Hold, but sit out down-signal daysHold all the time, except: sell at the close before a day when all three methods point down, stay in cash through that day (and any down days right after it), buy back at the close of the last one. | $24,868 | +8.0% | +6.3% | 386 | 55% | +0.32% | −60% | $20,502 |
Growth of $10,000 under each rule (log scale)
Each line is the value of $10,000 following one rule from January 2015. On a log scale, equal slopes mean equal percentage growth. Click the legend to add the weekly, monthly and other seasonal rules.
| Day type | Days | Open to close | Up days | Previous close to next open | Up |
|---|---|---|---|---|---|
| All three methods up | 721 | +0.019% | 51% | +0.11% | 54% |
| All three methods down | 534 | −0.009% | 48% | +0.09% | 52% |
| All days | 2,985 | +0.007% | 51% | +0.10% | 53% |
BSX seasonality data tables
Updated This BSX seasonality chart is built from 8,685 trading days of historical data, spanning from through — covering 35 years of market activity.
Sessions traded per month for BSX. Months with more sessions carry more weight in every seasonal average below.
Year-by-year performance for Boston Scientific Corporation, so a seasonal pattern can be read against the trend it sits inside.
How to read this BSX seasonality page
BSX seasonality FAQ
What is the best month for BSX stock?
Historically January: across 33 complete years (1993–2025) BSX averaged +5.4% in January and finished the month higher in 21 of 33 years. Its weakest month has been September (average −2.4%, higher in 13 of 33 years).
How has BSX performed in the next four weeks historically?
In the 20 trading sessions after November 13, BSX rose in 17 of 33 past years, with an average move of −0.9% and a median of +0.9%. This is a historical record, not a forecast.
What is BSX seasonality?
Seasonality is the tendency of a stock or fund to behave differently at particular points of the calendar. This page measures it for Boston Scientific Corporation three ways (by calendar date, by week and weekday, and by trading day of the month) across 8,685 trading sessions.
How are the seasonal averages calculated?
From daily closing prices, compounded rather than added, so a 10% gain followed by a 10% loss counts as the 1% loss it really is. Each year's year-to-date return is carried over weekends and holidays, and only complete calendar years enter the averages. Prices are adjusted for splits but not for dividends.
Why do the three seasonality methods sometimes disagree?
They line the data up differently. A calendar date falls on a different weekday and a different trading day of the month every year, so an effect driven by month-end flows shows clearly by trading day and only faintly by date. Agreement across all three is the stronger signal.
How current is the data?
Prices are refreshed automatically after each trading session and checked for gaps, duplicates, bad prints and unadjusted splits. The latest session on file is November 13, 2026.
Can seasonality be traded on its own?
No. These are historical averages over a limited number of years, and any single year can differ completely. Treat a seasonal pattern as context for a decision you have other reasons to make, and read the disclaimer.
Full method: how SeasonalityCharts measures seasonality · Disclaimer
Data last refreshed November 13, 2026. Seasonality figures are historical averages drawn from 8,685 trading sessions; they are not a forecast, and nothing on this page is investment advice. Please do your own research and see the Disclaimer.
